SLENDER-IO

SLENDER-IO
Product Description

It is a global innovation to reduce weight and act on all aspects involved in its increase, and the associated risk factors, competing in the market with GPL-1 agonist drugs without their adverse effects.
Increase levels of GLP-1 and CCK, giving a feeling of a full stomach.Increase energy levels and stimulate the nervous system. Increase serotonin levels helping to control mood and avoiding cravings. Reduces levels of fat circulation, preventing the subsequent storage and generation of fat. Helps eliminate fat and regulate glucose levels. Reduces body volume by burning and mobilizing accumulated fat.

Its bioavailability is 20% higher than other solutions thanks to its spray administration method. It is more effective than other solutions even at lower doses. It is safer and without the adverse effects of the most used treatments. It can be used discreetly every...

Prospectia Overseas Consulting SL

  • ES
  • 2021
    On CPHI since
  • 3
    Certificates
  • 1 - 24
    Employees
Company types
Distributor/Import Export
Primary activities
Finished Formulation products Distributor/Buyer
Specifications
  • Selling Points
    Weight Loss Management; •Increase the feeling of satiety.•Increase he levels of energy.•Increase efficiency in the glucose metabolization process.•Reduces anxiety and the desire to eat.•Reduces body volume.•Reduces cortisol levels, promoting stress control.•Reduces accumulated fat.

    “Slender-IO© Spray combined with a diet it can help you lose 5.42 kg in just 4 weeks of treatment, that is, 24.68% more effective than following the diet alone.” - Results of the San Francisco Clinic study. León, 2017.
  • Supplied from
    Spain

Prospectia Overseas Consulting SL

  • ES
  • 2021
    On CPHI since
  • 3
    Certificates
  • 1 - 24
    Employees
Company types
Distributor/Import Export
Primary activities
Finished Formulation products Distributor/Buyer

More Products from Prospectia Overseas Consulting SL (1)

  • Chemofoot

    Product Chemofoot

    Cream for therapy of Hand Foot Syndrome is a medical device in form of cream, rich in ingredients which form on skin moisturising-lubricating, protective-regenerative barrier.

Prospectia Overseas Consulting SL resources (1)

  • Brochure CHEMOFOOT -

    Associated with multikinase inhibitors (Sunitinib, Axitinib…) and with agents such as 5-fluorouracil, doxorubicin, and capecitabine, Hand Foot Syndrome is a highly prevalent side effect in oncology treatments.The therapeutic cream for hand-foot syndrome is a Medical Device in the form of a cream, rich in ingredients that form a moisturizing -l ubricating and protective - regenerative barrier on the skin.